摘要
Objective To provide reference for improving drug procurement with target quantity in China.Methods Documents on drug centralized procurement such as the “Guidance on Drug Procurement with Target Quantity for 4+7 Cities” issued by National Healthcare Security Administration in November 2018 and “Notice on the National Organization of the Pilot Program for Drug Centralized Procurement and Use of Bidding Drugs” issued by the State Council were studied to summarize the mode and result of drug procurement with target quantity.Results and Conclusion Drug procurement with target quantity led by National Healthcare Security Administration solved some problems in the previous centralized drug procurement.For instance,quantity could not determine drug price,and medical institutions didn’t pay to pharmaceutical companies on time.However,this new mode may also arouse new problems such as procurement monopoly,drug shortage,drug quality and inhibition of innovation.
